Researchers at the University of California, Irvine and the Italian Institute of Technology have developed a new molecule, ALY101, that shows promising anti-cancer activity against a wide range of tumor cell types and in ...
Apr 6, 2022
0
65
COVID-19 remains a significant challenge the world over. Research in the International Journal of Computational Biology and Drug Design, discusses how X-ray images and CT (computerized tomography) scans can reveal much about ...
Mar 23, 2022
0
2
Developing new drugs is a difficult process. With the aid of artificial intelligence, Pharmaceutical scientist Xuhan Liu has developed methods that can help make drug design cheaper and faster. His Ph.D. defense is on 15 ...
Feb 9, 2022
0
3
An international team of scientists and pharmaceutical collaborators has made a breakthrough "bench to bedside" discovery, ten years in the making, which they hope will advance the future treatment of Alzheimer's disease ...
Nov 26, 2021
0
79
New research published in the International Journal of Computational Biology and Drug Design describes a novel lipopeptide antibiotic that can inhibit the replication of the SARS-CoV-2 virus, which causes COVID-19. The compound, ...
Nov 10, 2021
0
8
Using a technique that could point to a new way to help people with severe anxiety and other treatment-resistant psychiatric illnesses, researchers at the University of Wisconsin–Madison successfully dialed down anxious ...
May 12, 2021
0
72
The Drug Design and Molecular Topology Unit group of the University of Valencia has shown that certain macrolide antibiotics (used in respiratory tract infections), including clarithromycin and azithromycin, can prevent the ...
Apr 26, 2021
0
12
Scientists have found new, unexpected behaviors when SARS-CoV-2—the virus that causes COVID-19—encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Mar 23, 2021
0
187
The Netherlands, Australia, New Zealand and the United States are consuming the highest amounts of designer 'party' drugs, according to wastewater samples taken from eight countries over the New Year period.
Feb 22, 2021
0
97
Made in clandestine laboratories and sold widely across the United States, the diverse class of drugs known as synthetic cannabinoids presents a growing public health threat.
Dec 16, 2020
0
5
